PL2575787T3 - Formulacje farmaceutyczne statyn i kwasów tłuszczowych omega-3 do kapsułkowania - Google Patents

Formulacje farmaceutyczne statyn i kwasów tłuszczowych omega-3 do kapsułkowania

Info

Publication number
PL2575787T3
PL2575787T3 PL11789014T PL11789014T PL2575787T3 PL 2575787 T3 PL2575787 T3 PL 2575787T3 PL 11789014 T PL11789014 T PL 11789014T PL 11789014 T PL11789014 T PL 11789014T PL 2575787 T3 PL2575787 T3 PL 2575787T3
Authority
PL
Poland
Prior art keywords
statins
omega
encapsulation
fatty acids
pharmaceutical formulations
Prior art date
Application number
PL11789014T
Other languages
English (en)
Inventor
Peter Draper
James Draper
Beth Okutan
Original Assignee
Catalent Ontario Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Ontario Limited filed Critical Catalent Ontario Limited
Publication of PL2575787T3 publication Critical patent/PL2575787T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL11789014T 2010-06-03 2011-06-03 Formulacje farmaceutyczne statyn i kwasów tłuszczowych omega-3 do kapsułkowania PL2575787T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2706270A CA2706270C (en) 2010-06-03 2010-06-03 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
PCT/CA2011/000650 WO2011150505A1 (en) 2010-06-03 2011-06-03 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
EP11789014.5A EP2575787B1 (en) 2010-06-03 2011-06-03 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation

Publications (1)

Publication Number Publication Date
PL2575787T3 true PL2575787T3 (pl) 2020-11-02

Family

ID=45066009

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11789014T PL2575787T3 (pl) 2010-06-03 2011-06-03 Formulacje farmaceutyczne statyn i kwasów tłuszczowych omega-3 do kapsułkowania

Country Status (12)

Country Link
US (3) US11975108B2 (pl)
EP (3) EP3581173B1 (pl)
JP (2) JP5972261B2 (pl)
AU (1) AU2011261117B2 (pl)
CA (1) CA2706270C (pl)
DK (1) DK2575787T3 (pl)
ES (1) ES2807498T3 (pl)
HU (1) HUE050830T2 (pl)
MX (2) MX369477B (pl)
PL (1) PL2575787T3 (pl)
PT (1) PT2575787T (pl)
WO (1) WO2011150505A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014095628A1 (en) * 2012-12-17 2014-06-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
ES2826201T3 (es) 2013-10-30 2021-05-17 Patheon Softgels Inc Cápsulas entéricas blandas que comprenden ácidos grasos poliinsaturados
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
CA2939990C (en) 2014-02-28 2018-07-10 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
WO2015185240A1 (en) 2014-06-04 2015-12-10 Sigma-Tau Industrire Farmaceutiche Riunite S.P.A. Compositions containing simvastatin in omega-3 polyunsaturated fatty acids
WO2015200563A1 (en) * 2014-06-26 2015-12-30 Banner Life Sciences Llc Enhanced bioavailability of polysaturated fatty acids
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
KR101752700B1 (ko) * 2014-08-13 2017-07-03 한국유나이티드제약 주식회사 오메가-3 지방산 에스테르 및 스타틴계 약물을 포함하는 경구용 복합제제
KR101950907B1 (ko) * 2016-02-05 2019-02-21 한국유나이티드제약 주식회사 지용성 약물 및 방유성 기제가 코팅된 고형제제를 포함하는 경구용 복합제제
WO2017171484A1 (ko) * 2016-03-31 2017-10-05 한미약품 주식회사 오메가-3 지방산 또는 이의 에스테르, 및 하이드록시메틸글루타릴 코엔자임에이 환원효소 억제제를 포함하는 경구용 복합 제제
US11547693B2 (en) 2019-07-29 2023-01-10 Matthias Rath Ascorbate in the prevention of statin induced vascular calcification
US10736872B1 (en) * 2019-09-05 2020-08-11 Matthias W. Rath Pharmaceutical mixture to treat statin induced vascular calcification
WO2021142062A1 (en) 2020-01-10 2021-07-15 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
EP4185277A4 (en) * 2020-07-23 2024-08-07 Procaps SA Soft shell gelatin capsules
BR102021011153B1 (pt) 2021-06-09 2022-12-27 Fernando Campos Barbosa Composição fitoterápica associada a suplementos polivitamínicos e minerais
MX2023000990A (es) * 2021-07-23 2023-04-27 Procaps Sa Capsulas de gelatina de cascara blanda que incorporan formas farmaceuticas de liberacion inmediata y prolongada y sus metodos de fabricacion.
MX2024011226A (es) 2024-09-12 2026-04-01 Laboratorios Silanes S A De C V Composicion farmaceutica que comprende rosuvastatina y omega 3, proceso de preparacion y usos de la misma

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1803440A (en) * 1929-07-25 1931-05-05 Newspaper Mechanical Sales Com Coin control for vending machines
US2775080A (en) 1950-05-26 1956-12-25 American Cyanamid Co Method of forming powder-and-liquid filled capsules
US2711814A (en) * 1953-08-14 1955-06-28 Bartlett And Company Grain Apparatus for cleaning flat bottom grain tanks
US3536074A (en) 1968-03-29 1970-10-27 Alfred Aufhauser Oral administration of a pill,tablet or capsule
US4655027A (en) 1980-11-24 1987-04-07 Chasman Sydney A Method and apparatus for forming capsules
WO1995000125A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Soft-shelled gelatin encapsulated particles
EP1017390B1 (en) * 1997-07-31 2007-04-18 Kos Life Sciences, Inc. Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form
US6238616B1 (en) 1998-12-14 2001-05-29 Timecaps Inc. Method of manufacturing gelatin capsule containing powder or time release pellets
US6574945B2 (en) 2001-03-21 2003-06-10 Lumitek Llc Method for manufacturing a projectile containing chemiluminescent compounds
WO2002100394A1 (en) * 2001-06-12 2002-12-19 Galephar M/F Oral pharmaceutical composition containing a statin derivative
AU2003253018A1 (en) 2002-06-25 2004-01-06 Akzo Nobel N.V. Use of cationic layered materials, compositions comprising these materials, and the preparation of cationic layered materials
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040146537A1 (en) * 2003-01-28 2004-07-29 Ramachandran Radhakrishnan Oily wax matrix suspension formulation comprising pharmacologically active agents
CA2475765A1 (en) * 2003-07-29 2005-01-29 L. Perrigo Company Tablet encapsulating machine
RU2315755C2 (ru) * 2003-09-17 2008-01-27 Уорнер-Ламберт Компани Ллс Кристаллические формы [r-(r*,r*)]-2-(4-фторфенил)-бета, дельта-дигидрокси-5-(1-метилэтил)-3-фенил-4-[(фениламино)карбонил]-1н-пиррол-1-гептановой кислоты
CN1993121A (zh) * 2004-08-06 2007-07-04 变换药品公司 新的他汀药物组合物及相关治疗方法
ES2255426B1 (es) * 2004-10-19 2007-08-16 Gp Pharm, S.A. Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
US20070191467A1 (en) * 2004-12-06 2007-08-16 Reliant Pharmaceutical, Inc. Statin and omega-3 fatty acids for lipid therapy
MX2007011031A (es) * 2005-03-08 2008-04-21 Reliant Pharmaceuticals Inc Tratamiento con estatina y acidos grasos omega-3 y un producto de combinacion de los mismos.
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
EP1968567B1 (en) * 2005-12-20 2014-06-18 Cenestra, Llc Omega 3 fatty acid formulations
EP2081550B2 (en) * 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US8784886B2 (en) 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
US20070218141A1 (en) * 2006-03-15 2007-09-20 Ashis Kumar Mehta Simvastatin compositions
CA2655615A1 (en) * 2006-06-26 2008-12-17 Valpharma S.A. A pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
EP2431043A1 (en) * 2007-05-23 2012-03-21 Amcol International Corporation Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
EP2455070A1 (en) * 2008-01-10 2012-05-23 Takeda Pharmaceutical Company Limited Capsule Formulation
US20110082119A1 (en) * 2008-06-13 2011-04-07 Takashi Yano Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
GB0818472D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
CA2706272C (en) 2010-06-03 2020-05-05 Accucaps Industries Limited Multi phase soft gel capsules, apparatus and method thereof

Also Published As

Publication number Publication date
ES2807498T3 (es) 2021-02-23
MX369477B (es) 2019-11-08
PT2575787T (pt) 2020-07-28
US20130115281A1 (en) 2013-05-09
JP2013527205A (ja) 2013-06-27
JP5972261B2 (ja) 2016-08-17
EP4445959A2 (en) 2024-10-16
WO2011150505A1 (en) 2011-12-08
US20230233472A1 (en) 2023-07-27
EP2575787A1 (en) 2013-04-10
HUE050830T2 (hu) 2021-01-28
EP3581173C0 (en) 2024-08-28
MX2019013095A (es) 2020-01-30
US20260224501A1 (en) 2026-08-06
EP2575787B1 (en) 2020-05-27
JP2016138143A (ja) 2016-08-04
US11975108B2 (en) 2024-05-07
AU2011261117B2 (en) 2015-08-13
MX2012013933A (es) 2013-02-11
EP4445959A3 (en) 2025-01-08
AU2011261117A1 (en) 2012-12-13
DK2575787T3 (da) 2020-08-03
EP3581173B1 (en) 2024-08-28
EP3581173A1 (en) 2019-12-18
CA2706270C (en) 2020-01-07
CA2706270A1 (en) 2011-12-03
US12544341B2 (en) 2026-02-10
EP2575787A4 (en) 2013-11-27

Similar Documents

Publication Publication Date Title
PT2575787T (pt) Formulações farmacêuticas de estatinas e ácidos gordos ómega-3 para o encapsulamento
ZA201202263B (en) Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
EP2846779A4 (en) STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
IL228516A (en) A compound for oral administration containing an omega-3 fatty acid ester and rosovastatin
EP2498602A4 (en) STABILIZED FORMULATIONS FROM FATTY ACIDS
IL234104A (en) METHOD FOR PREPARING Medium-length fatty acids with triglycerides
IL234814A (en) Omega 3 fatty acid ester preparations
EP2822923A4 (en) PREPARATION OF ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS AND ESTERS THEREOF
EP2827868B8 (en) Pharmaceutical compositions comprising fatty acid esters
ZA201302760B (en) Novel omega-3 and omega-6 fatty acid compositions and uses thereof
HUE051850T2 (hu) Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra
EP2706847A4 (en) COUPLERS FOR MEDIUM CHAIN FATTY ACIDS AND DISINFECTANT COMPOSITIONS
IL232748A0 (en) Preparations including fatty acids with 20 carbons and methods for their preparation and use
ZA201400336B (en) Fatty acid composition and plant extract and pharmaceutical preparation and application thereof
EP2560633B8 (en) Intravenous omega-3 fatty acid compositions & method of use
HUE055771T2 (hu) Naproxén gyógyászati kiszerelései lágy gél kapszulázáshoz, és ezek kombinációi
IL213354A (en) Alpha-monoclonal fatty acid alpha history for use as a drug
GB201304550D0 (en) Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
EP2599484A4 (en) INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE
SI2525827T1 (sl) Farmacevtske formulacije loratadina za inkapsulacijo in njihove kombinacije
EP2845585A4 (en) COMPOSITION OF FATTY ACID ESTERS OF TRHEHALOSIS
AU2010903057A0 (en) Acetylenation of fatty acids
PL391825A1 (pl) Sposób otrzymywania estrów i laktonów
ZA201105275B (en) Pharmaceutical formulation containing atorvastatin and method for the preparation thereof